MENU
JANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Janux Therapeutics (JANX) Earnings Date & Reports

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer... Show more

A.I. Advisor
published Earnings

JANX is expected to report earnings to rise 35.40% to -47 cents per share on November 10

Janux Therapeutics JANX Stock Earnings Reports
Q3'26
Est.
$-0.47
Q2'26
Missed
by $0.08
Q1'26
Beat
by $0.18
Q4'25
Beat
by $0.11
Q3'25
Beat
by $0.23
The last earnings report on August 06 showed earnings per share of -34 cents, missing the estimate of -27 cents. With 199.81K shares outstanding, the current market capitalization sits at 1.01B.
View a ticker or compare two or three
JANX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
109
Web
https://www.januxrx.com